Overview
Brian Leberthon is a Hematologist in West Covina, California. Dr. Leberthon is rated as an Experienced provider by MediFind in the treatment of Prekallikrein Deficiency. His top areas of expertise are Polycythemia Vera, Familial Prostate Cancer, Hereditary Resistance to Anti-Vitamin K, and Congenital Antithrombin 3 Deficiency.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1135 S Sunset Ave Ste 207, West Covina, CA 91790
Mark Ngo is a Hematologist and an Oncologist in Torrance, California. Dr. Ngo is rated as an Advanced provider by MediFind in the treatment of Prekallikrein Deficiency. His top areas of expertise are Thrombocytopenia, Drug-Induced Thrombocytopenia, Mediastinal Tumor, and Paget Disease of the Breast. Dr. Ngo is currently accepting new patients.
Cedars-Sinai Cancer-Beverly Hills
David Hoffman is a Hematologist and an Oncologist in Beverly Hills, California. Dr. Hoffman is rated as a Distinguished provider by MediFind in the treatment of Prekallikrein Deficiency. His top areas of expertise are Iron Deficiency Anemia, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Myelodysplastic Syndrome (MDS).
USC Norris Comprehensive Cancer Center And Hospital
Casey O'connell is a Hematologist in Los Angeles, California. Dr. O'connell is rated as an Elite provider by MediFind in the treatment of Prekallikrein Deficiency. Her top areas of expertise are Polycythemia Vera, Myelofibrosis, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Splenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult Immune ThrombocytopeniaDr. Leberthon isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Leberthon isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Leberthon isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Leberthon isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Leberthon isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Leberthon isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Experienced
- Acute Mountain SicknessDr. Leberthon isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Leberthon isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaDr. Leberthon isExperienced. Learn about Adult T-Cell Leukemia.
- ALK-Positive Non-Small Cell Lung CancerDr. Leberthon isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Leberthon isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Leberthon isExperienced. Learn about Anal Cancer.